Diagnostic efficacy of risk of malignancy index in adnexal mass: a prospective study
Objectives: The purpose of this study was to determine if the risk of malignancy index (RMI 2) can distinguish between benign and malignant adnexal masses in the women with adnexal masses. Methods: This is a prospective observational study conducted over a period of two years from 2012 to 2014. A to...
Main Authors: | Anusha Kamath, Satyam Satyarth, Pariseema Dave |
---|---|
Format: | Article |
Language: | English |
Published: |
Barpeta Obstetrics and Gynaecological Society
2020-07-01
|
Series: | New Indian Journal of OBGYN |
Subjects: | |
Online Access: | https://journal.barpetaogs.co.in/pdf/074.pdf |
Similar Items
-
Serum biomarkers for differential diagnosis of adnexal masses in pregnant women
by: S A Martynov, et al.
Published: (2014-08-01) -
Validity of the Risk of Malignancy Index 4 to Preoperative Evaluation of Patients with Adnexal Masses
by: Ornwitsanate Mongkolmafai, et al.
Published: (2016-12-01) -
Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial
by: Vincent Dochez, et al.
Published: (2019-10-01) -
Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers
by: Maria Lycke, et al.
Published: (2020-01-01) -
Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass
by: Khawla Al Musalhi, et al.
Published: (2016-09-01)